Genetics of neuromuscular disorders

References

• Emery AEH. Molecular Genetics of Neuromuscular Disorders: applications in clinical medicine. In: Emery AEH, editor. Neuromuscular Disorders: clinical and molecular genetics. Chichester, New York, Weinheim, Brisbane, Singapore, Toronto: John Wiley and Sons, 1998. p. 1–20.
   Google Scholar
• Ravenscroft G, Sollis E, Charles AK, North KN, Baynam G, Laing NG. Fetal akinesia: review of the genetics of the neuromuscular causes. J Med Genet 2011;48:793–801.
   PubMed Web of Science ®Google Scholar
• Krivosic-Horber R, Dépret T, Wagner JM, Maurage CA. Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatment. Eur J Anaesthesiol 2004;21:572–574.
   Google Scholar
• Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, et al.; SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy – a genomewide study. N Engl J Med 2008;359:789–799.
   PubMed Web of Science ®Google Scholar
• Supala-Berger A, Fine E, Heffner R, Young-McLain E. Hyaline inclusion myopathy: unmasked by statin therapy. Muscle Nerve 2009;40:657–661.
   Google Scholar
• Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002;12:926–929.
   PubMed Web of Science ®Google Scholar
• Wallgren-Pettersson C, Bushby K, Mellies U, Simonds A; ENMC. 117th ENMC workshop: ventilatory support in congenital neuromuscular disorders – congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 April 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:56–69.
   PubMedGoogle Scholar
• Sejerson T, Bushby K; TREAT-NMD EU Network of Excellence. Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations. Adv Exp Med Biol 2009;652:13–21.
   Web of Science ®Google Scholar
• Dubowitz V, Sewry CA. Muscle Biopsy a practical approach. 3rd ed: Saunders Elsevier; 2007.
   Google Scholar
• de Visser M, Reimers CD. Muscle Imaging. In: Engel AG, Franzini-Armstrong C, editors. Myology. 3rd ed. New York: McGraw-Hill; 2004. p. 655–663.
   Google Scholar
• Jungbluth H, Sewry CA, Counsell S, Allsop J, Chattopadhyay A, Mercuri E, et al. Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord 2004;14:779–784.
   PubMed Web of Science ®Google Scholar
• Mercuri E, Jungbluth H, Muntoni F. Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 2005;18:526–537.
   PubMed Web of Science ®Google Scholar
• Fischer D, Kley RA, Strach K, Meyer C, Sommer T, Eger K, et al. Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 2008;71:758–765.
   PubMed Web of Science ®Google Scholar
• Mercuri E, de Visser M. Diagnostic imaging of muscle. In: Karpati G, Hilton-Jones D, Bushby K, Griggs RC, editors. Disorders of Voluntary Muscle, 8th Edition. Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, Sao Paulo, Delhi, Dubai, Tokyo: Cambridge University Press; 2010. p. 151–161.
   Google Scholar
• Klein A, Jungbluth H, Clement E, Lillis S, Abbs S, Munot P, et al. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch Neurol 2011;68:1171–1179.
   PubMedGoogle Scholar
• Bundey S. Calculation of genetic risks in Duchenne muscular dystrophy by geneticists in the United Kingdom. J Med Genet 1978;15:249–253.
   Google Scholar
• Emery AEH, Emery MLH. The history of a genetic disease. Duchenne muscular dystrophy or Meryon’s disease. London, New York: Royal Society of Medicine Press Ltd; 1995.
   Google Scholar
• Emery AE. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br Med Bull 1980;36:117–122.
   Google Scholar
• Haldane JBS. The rate of spontaneous mutation of a human gene. J Genet 1935;31:317–326.
   Google Scholar
• Hurse PV, Kakulas BA. Genetic counselling in neuromuscular diseases in Western Australia. Proc Aust Assoc Neurol 1974;11:145–153.
   Google Scholar
• Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V, et al. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord 2008;18:34–44.
   PubMed Web of Science ®Google Scholar
• Peat RA, Smith JM, Compton AG, Baker NL, Pace RA, Burkin DJ, et al. Diagnosis and etiology of congenital muscular dystrophy. Neurology 2008;71:312–321.
   Google Scholar
• UK Human Genetics Commission. Increasing options, informing choice: A report on preconception genetic testing and screening. 2011.
   Google Scholar
• Collins FS. Positional cloning moves from perditional to traditional. Nat Genet 1995;9:347–350.
   PubMed Web of Science ®Google Scholar
• Wirth B, Rudnik-Schöneborn S, Hahnen E, Röhrig D, Zerres K. Prenatal prediction in families with autosomal recessive proximal spinal muscular atrophy (5q11.2-q13.3): molecular genetics and clinical experience in 109 cases. Prenat Diagn 1995;15:407–417.
   Google Scholar
• Abbs S, Roberts RG, Mathew CG, Bentley DR, Bobrow M. Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene. Genomics 1990;7:602–606.
   Google Scholar
• Bakker E, Hofker MH, Goor N, Mandel JL, Wrogemann K, Davies KE, et al. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet 1985;1:655–658.
   Google Scholar
• Dorkins H, Junien C, Mandel JL, Wrogemann K, Moison JP, Martinez M, et al. Segregation analysis of a marker localised Xp21.2-Xp21.3 in Duchenne and Becker muscular dystrophy families. Hum Genet 1985;71:103–107.
   Google Scholar
• Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509–517.
   PubMed Web of Science ®Google Scholar
• Monaco AP, Bertelson CJ, Middlesworth W, Colletti CA, Aldridge J, Fischbeck KH, et al. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 1985;316:842–845.
   Google Scholar
• Bakker E, Bonten EJ, De Lange LF, Veenema H, Majoor-Krakauer D, Hofker MH, et al. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet 1986;23:573–580.
   Google Scholar
• Kunkel LM, Hejtmancik JF, Caskey CT, Speer A, Monaco AP, Middlesworth W, et al. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 1986;322:73–77.
   PubMed Web of Science ®Google Scholar
• Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988;2:90–95.
   PubMed Web of Science ®Google Scholar
• Laing NG, Mears ME, Thomas HE, Chandler DC, Layton MG, Goldblatt J, et al. Differentiation of Becker muscular dystrophy from limb-girdle muscular dystrophy and Kugelberg-Welander disease using a cDNA probe. Med J Aust 1990;152:270–271.
   Google Scholar
• Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45–48.
   PubMed Web of Science ®Google Scholar
• Prior TW, Bartolo C, Pearl DK, Papp AC, Snyder PJ, Sedra MS, et al. Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet 1995;57:22–33.
   PubMedGoogle Scholar
• Flanigan KM, von Niederhausern A, Dunn DM, Alder J, Mendell JR, Weiss RB. Rapid direct sequence analysis of the dystrophin gene. Am J Hum Genet 2003;72:931–939.
   PubMed Web of Science ®Google Scholar
• La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77–79.
   PubMed Web of Science ®Google Scholar
• Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219–232.
   PubMed Web of Science ®Google Scholar
• Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143–151.
   PubMed Web of Science ®Google Scholar
• Harper PS, Harley HG, Reardon W, Shaw DJ. Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet 1992;51:10–16.
   PubMed Web of Science ®Google Scholar
• Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992;355:548–551.
   PubMed Web of Science ®Google Scholar
• Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799–808.
   PubMed Web of Science ®Google Scholar
• Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, Aslanidis C, et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992;355:547–548.
   PubMed Web of Science ®Google Scholar
• Tsilfidis C, MacKenzie AE, Mettler G, Barceló J, Korneluk RG. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet 1992;1:192–195.
   PubMed Web of Science ®Google Scholar
• Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155–165.
   PubMed Web of Science ®Google Scholar
• Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997;61:40–50.
   PubMed Web of Science ®Google Scholar
• Jadayel D, Fain P, Upadhyaya M, Ponder MA, Huson SM, Carey J, et al. Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature 1990;343:558–559.
   PubMed Web of Science ®Google Scholar
• Valentijn LJ, Ouvrier RA, van den Bosch NH, Bolhuis PA, Baas F, Nicholson GA. Déjérine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum Mutat 1995;5:76–80.
   Google Scholar
• Silander K, Meretoja P, Nelis E, Timmerman V, Van Broeckhoven C, Aula P, et al. A de novo duplication in 17p11.2 and a novel mutation in the Po gene in two Déjérine-Sottas syndrome patients. Hum Mutat 1996;8:304–310.
   Google Scholar
• Baets J, Deconinck T, De Vriendt E, Zimon M, Yperzeele L, Van Hoorenbeeck K, et al. Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 2011;134:2664–2676.
   Google Scholar
• Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, et al. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet 1999;23:208–212.
   PubMed Web of Science ®Google Scholar
• Laing NG, Dye DE, Wallgren-Pettersson C, Richard G, Monnier N, Lillis S, et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1). Hum Mutat 2009;30:1267–1277.
   Google Scholar
• Wallgren-Pettersson C, Laing N. 40th ENMC Sponsored International Workshop: Nemaline Myopathy. 2-4 February 1996, Naarden, The Netherlands. Neuromuscul Disord 1996;6:389–391.
   Google Scholar
• Meredith C, Herrmann R, Parry C, Liyanage K, Dye DE, Durling HJ, et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am J Hum Genet 2004;75:703–708.
   PubMed Web of Science ®Google Scholar
• Dubourg O, Maisonobe T, Behin A, Suominen T, Raheem O, Penttilä S, et al. A novel MYH7 mutation occurring independently in French and Norwegian Laing distal myopathy families and de novo in one Finnish patient. J Neurol 2011;258:1157–1163.
   Google Scholar
• Laing NG, Sewry CA, Lamont P. Congenital Myopathies. In: Mastaglia FL, Hilton-Jones D, editors. Myopathies. Series 3 ed: Elsevier; 2007. p. 1–33.
   Google Scholar
• Brock DJ. A consortium approach to molecular genetic services. Scottish Molecular Genetics Consortium. J Med Genet 1990;27:8–13.
   Google Scholar
• Kelly KF. The Scottish molecular genetics consortium – 15 years on. Health Bull (Edinb) 2002;60:83–90.
   Google Scholar
• Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69:22–33.
   PubMed Web of Science ®Google Scholar
• von der Hagen M, Schallner J, Kaindl AM, Koehler K, Mitzscherling P, Abicht A, et al. Facing the genetic heterogeneity in neuromuscular disorders: linkage analysis as an economic diagnostic approach towards the molecular diagnosis. Neuromuscul Disord 2006;16:4–13.
   Google Scholar
• Wallgren-Pettersson C, Laing NG. Congenital myopathies. In: Karpati G, Hilton-Jones D, Bushby K, Griggs RC, editors. Disorders of Voluntary Muscle, 8th Edition. Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, Sao Paulo, Delhi, Dubai, Tokyo: Cambridge University Press; 2010. p. 282–298.
   Google Scholar
• Abbs S, Tuffery-Giraud S, Bakker E, Ferlini A, Sejersen T, Mueller CR. Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscul Disord 2010;20:422–427.
   Google Scholar
• Sewry CA, Jimenez-Mallebrera C, Muntoni F. Congenital myopathies. Curr Opin Neurol 2008;21:569–575.
   Google Scholar
• Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003;107:2227–2232.
   PubMed Web of Science ®Google Scholar
• Villard E, Duboscq-Bidot L, Charron P, Benaiche A, Conraads V, Sylvius N, et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 2005;26:794–803.
   PubMed Web of Science ®Google Scholar
• Tajsharghi H, Thornell LE, Lindberg C, Lindvall B, Henriksson KG, Oldfors A. Myosin storage myopathy associated with a heterozygous missense mutation in MYH7. Ann Neurol 2003;54:494–500.
   PubMedGoogle Scholar
• Tajsharghi H, Oldfors A, Macleod DP, Swash M. Homozygous mutation in MYH7 in myosin storage myopathy and cardiomyopathy. Neurology 2007;68:962.
   Google Scholar
• Pegoraro E, Gavassini BF, Borsato C, Melacini P, Vianello A, Stramare R, et al. MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy. Neuromuscul Disord 2007;17:321–329.
   Google Scholar
• Muelas N, Hackman P, Luque H, Garcés-Sánchez M, Azorín I, Suominen T, et al. MYH7 gene tail mutation causing myopathic profiles beyond Laing distal myopathy. Neurology 2010;75:732–741.
   Google Scholar
• Ortolano S, Tarrío R, Blanco-Arias P, Teijeira S, Rodríguez-Trelles F, García-Murias M, et al. A novel MYH7 mutation links congenital fiber type disproportion and myosin storage myopathy. Neuromuscul Disord 2011;21:254–262.
   Google Scholar
• Homayoun H, Khavandgar S, Hoover JM, Mohsen AW, Vockley J, Lacomis D, et al. Novel mutation in MYH7 gene associated with distal myopathy and cardiomyopathy. Neuromuscul Disord 2011;21:219–222.
   Google Scholar
• Zhang Y, Chen HS, Khanna VK, De Leon S, Phillips MS, Schappert K, et al. A mutation in the human ryanodine receptor gene associated with central core disease. Nat Genet 1993;5:46–50.
   PubMed Web of Science ®Google Scholar
• Quane KA, Healy JM, Keating KE, Manning BM, Couch FJ, Palmucci LM, et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 1993;5:51–55.
   PubMed Web of Science ®Google Scholar
• Monnier N, Romero NB, Lerale J, Nivoche Y, Qi D, MacLennan DH, et al. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet 2000;9:2599–2608.
   PubMed Web of Science ®Google Scholar
• Scacheri PC, Hoffman EP, Fratkin JD, Semino-Mora C, Senchak A, Davis MR, et al. A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology 2000;55:1689–1696.
   Google Scholar
• Sewry CA, Müller C, Davis M, Dwyer JS, Dove J, Evans G, et al. The spectrum of pathology in central core disease. Neuromuscul Disord 2002;12:930–938.
   PubMedGoogle Scholar
• Sato I, Wu S, Ibarra MC, Hayashi YK, Fujita H, Tojo M, et al. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology 2008;70:114–122.
   Google Scholar
• Ferreiro A, Monnier N, Romero NB, Leroy JP, Bönnemann C, Haenggeli CA, et al. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann Neurol 2002;51:750–759.
   Google Scholar
• Jungbluth H, Müller CR, Halliger-Keller B, Brockington M, Brown SC, Feng L, et al. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology 2002;59:284–287.
   PubMed Web of Science ®Google Scholar
• Davis M, Brown R, Dickson A, Horton H, James D, Laing N, et al. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Br J Anaesth 2002;88:508–515.
   Google Scholar
• Jungbluth H, Zhou H, Bertini E, Treves S, Sewry C, Muntoni F. Autosomal dominant mutations in the human ryanodine receptor (RYR1) gene associated with centronuclear myopathy. Neuromuscul Disord 2005;15:681.
   Google Scholar
• Jungbluth H, Zhou H, Hartley L, Halliger-Keller B, Messina S, Longman C, et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology 2005;65:1930–1935.
   PubMed Web of Science ®Google Scholar
• Clarke NF, Waddell LB, Cooper ST, Perry M, Smith RL, Kornberg AJ, et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum Mutat 2010;31:E1544–E1550.
   Google Scholar
• Fee DB, So YT, Barraza C, Figueroa KP, Pulst SM. Phenotypic variability associated with Arg26Gln mutation in caveolin3. Muscle Nerve 2004;30:375–378.
   Google Scholar
• Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002;71:492–500.
   PubMed Web of Science ®Google Scholar
• Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 1999;262:411–417.
   PubMed Web of Science ®Google Scholar
• Gerull B, Gramlich M, Atherton J, McNabb M, Trombitás K, Sasse-Klaassen S, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002;30:201–204.
   PubMed Web of Science ®Google Scholar
• Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005;308:1599–1603.
   PubMed Web of Science ®Google Scholar
• Carmignac V, Salih MA, Quijano-Roy S, Marchand S, Al Rayess MM, Mukhtar MM, et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol 2007;61:340–351.
   Google Scholar
• Donner K, Sandbacka M, Lehtokari VL, Wallgren-Pettersson C, Pelin K. Complete genomic structure of the human nebulin gene and identification of alternatively spliced transcripts. Eur J Hum Genet 2004;12:744–751.
   PubMed Web of Science ®Google Scholar
• Pelin K, Hilpelä P, Donner K, Sewry C, Akkari PA, Wilton SD, et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci USA 1999;96:2305–2310.
   PubMed Web of Science ®Google Scholar
• Lehtokari VL, Pelin K, Sandbacka M, Ranta S, Donner K, Muntoni F, et al. Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat 2006;27:946–956.
   Google Scholar
• Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006;27:977–989.
   Google Scholar
• Davis MR, Haan E, Jungbluth H, Sewry C, North K, Muntoni F, et al. Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Neuromuscul Disord 2003;13:151–157.
   Google Scholar
• Wu S, Ibarra MC, Malicdan MC, Murayama K, Ichihara Y, Kikuchi H, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain 2006;129:1470–1480.
   Google Scholar
• Consortium* TGP. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061–1073.
   Google Scholar
• Kono S, Nishio T, Takahashi Y, Goto-Inoue N, Kinoshita M, Zaima N, et al. Dominant-negative effects of a novel mutation in the filamin myopathy. Neurology 2010;75:547–554.
   Google Scholar
• Odgerel Z, van der Ven PF, Fürst DO, Goldfarb LG. DNA sequencing errors in molecular diagnostics of filamin myopathy. Clin Chem Lab Med 2010;48:1409–1414.
   Google Scholar
• Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001;10:591–597.
   PubMed Web of Science ®Google Scholar
• Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812–3814.
   PubMed Web of Science ®Google Scholar
• Grantham R. Amino acid difference formula to help explain protein evolution. Science 1974;185:862–864.
   PubMed Web of Science ®Google Scholar
• Tabet AC, Aboura A, Gérard M, Pilorge M, Dupont C, Gadisseux JF, et al. Molecular characterization of a de novo 6q24.2q25.3 duplication interrupting UTRN in a patient with arthrogryposis. Am J Med Genet A 2010;152A:1781–1788.
   Google Scholar
• Saillour Y, Cossée M, Leturcq F, Vasson A, Beugnet C, Poirier K, et al. Detection of exonic copy-number changes using a highly efficient oligonucleotide-based comparative genomic hybridization-array method. Hum Mutat 2008;29:1083–1090.
   Google Scholar
• Cheng S, Higuchi R, Stoneking M. Complete mitochondrial genome amplification. Nat Genet 1994;7:350–351.
   PubMed Web of Science ®Google Scholar
• Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57.
   PubMed Web of Science ®Google Scholar
• Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, et al. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 1996;33:1022–1026.
   PubMed Web of Science ®Google Scholar
• Radvansky J, Ficek A, Kadasi L. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing. Genet Test Mol Biomarkers 2011;15:133–136.
   Google Scholar
• Catalli C, Morgante A, Iraci R, Rinaldi F, Botta A, Novelli G. Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2). J Mol Diagn 2010;12:601–606.
   PubMedGoogle Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245–256.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257–268.
   PubMed Web of Science ®Google Scholar
• van der Steege G, Grootscholten PM, van der Vlies P, Draaijers TG, Osinga J, Cobben JM, et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995;345:985–986.
   PubMed Web of Science ®Google Scholar
• Hildebrandt F, Heeringa SF, Rüschendorf F, Attanasio M, Nürnberg G, Becker C, et al. A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLoS Genet 2009;5:e1000353.
   Google Scholar
• Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874–879.
   PubMed Web of Science ®Google Scholar
• Lemmers RJ, Wohlgemuth M, Frants RR, Padberg GW, Morava E, van der Maarel SM. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004;75:1124–1130.
   PubMed Web of Science ®Google Scholar
• Metzker ML. Sequencing technologies – the next generation. Nat Rev Genet 2010;11:31–46.
   PubMed Web of Science ®Google Scholar
• Lalonde E, Albrecht S, Ha KC, Jacob K, Bolduc N, Polychronakos C, et al. Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next-generation exome sequencing. Hum Mutat 2010;31:918–923.
   PubMed Web of Science ®Google Scholar
• Clark MJ, Chen R, Lam HY, Karczewski KJ, Chen R, Euskirchen G, Butte AJ, et al. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 2011;29:908–914.
   PubMed Web of Science ®Google Scholar
• Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010;68:857–864.
   PubMed Web of Science ®Google Scholar
• Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30–35.
   PubMed Web of Science ®Google Scholar
• Weedon MN, Hastings R, Caswell R, Xie W, Paszkiewicz K, Antoniadi T, et al. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 2011;89:308–312.
   PubMed Web of Science ®Google Scholar
• Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010;362:1181–1191.
   PubMed Web of Science ®Google Scholar
• Agrawal PB, Greenleaf RS, Tomczak KK, Lehtokari VL, Wallgren-Pettersson C, Wallefeld W, et al. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet 2007;80:162–167.
   PubMed Web of Science ®Google Scholar
• Ockeloen CM, Gilhuis HJ, Pfundt R, Kamsteeg EJ, Beggs AH, Amin AD-H, et al. Nemaline myopathy caused by a novel missense mutation in the CFL2 gene. Neuromuscul Disord 2011;21:696.
   Google Scholar
• Montenegro G, Powell E, Huang J, Speziani F, Edwards YJ, Beecham G, et al. Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family. Ann Neurol 2011;69:464–470.
   PubMed Web of Science ®Google Scholar
• Hoischen A, Gilissen C, Arts P, Wieskamp N, van derVliet W, Vermeer S, et al. Massively parallel sequencing of ataxia genes after array-based enrichment. Hum Mutat 2010;31:494–499.
   PubMed Web of Science ®Google Scholar
• Walsh T, Lee MK, Casadei S, Thornton AM, Stray SM, Pennil C, et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 2010;107:12629–12633.
   PubMed Web of Science ®Google Scholar
• Simpson DA, Clark GR, Alexander S, Silvestri G, Willoughby CE. Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa. J Med Genet 2011;48:145–151.
   PubMed Web of Science ®Google Scholar
• Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009;461:272–276.
   PubMed Web of Science ®Google Scholar
• Bradley DM, Parsons EP, Clarke AJ. Experience with screening newborns for Duchenne muscular dystrophy in Wales. BMJ 1993;306:357–360.
   PubMed Web of Science ®Google Scholar
• Roses AD. Mutants in Duchenne muscular dystrophy. Implications for prevention. Arch Neurol 1988;45:84–85.
   Google Scholar
• Laing NG. Multiplicity of experimental approaches to therapy for genetic muscle diseases and necessity for population screening. J Muscle Res Cell Motil 2008;29:247–252.
   Google Scholar
• Zlotogora J. Population programs for the detection of couples at risk for severe monogenic genetic diseases. Hum Genet 2009;126:247–253.
   PubMed Web of Science ®Google Scholar
• Kaback MM. Screening and prevention in Tay-Sachs disease: origins, update, and impact. Adv Genet 2001;44:253–265.
   Google Scholar
• Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011;3:65ra4.
   PubMed Web of Science ®Google Scholar
• Bartoli M, Gicquel E, Barrault L, Soheili T, Malissen M, Malissen B, et al. Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation. Hum Mol Genet 2008;17:1214–1221.
   PubMed Web of Science ®Google Scholar
• Castets P, Bertrand AT, Beuvin M, Ferry A, Le Grand F, Castets M, et al. Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency. Hum Mol Genet 2011;20:694–704.
   Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Dalakas MC. Inflammatory myopathies: management of steroid resistance. Curr Opin Neurol 2011;24:457–462.
   PubMed Web of Science ®Google Scholar
• Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 2011;378:595–605.
   PubMed Web of Science ®Google Scholar
• Nowak KJ, Sewry CA, Navarro C, Squier W, Reina C, Ricoy JR, et al. Nemaline myopathy caused by absence of alpha-skeletal muscle actin. Ann Neurol 2007;61:175–184.
   Google Scholar
• Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. “Sporadic” motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet 1994;344:1773.
   PubMedGoogle Scholar